6505--BridgeBio Pharma, Inc. Award date Effective: 7/31/2025 to 7/30/2030 M5Q50A03R8
Summary
AI-generated · Aug 24, 2025Three award notices under program 6505 have been issued to BRIDGEBIO PHARMA, INC., SOLENO THERAPEUTICS INC, and IONIS PHARMACEUTICALS, INC. One recipient, BridgeBio Pharma, received a funded award of $250,000, with a multi-year term extending through the latter part of the period. The other two awardees show award notices with an award amount of $0 at the time of award, also tied to multi-year terms.
The change across notices shows a funded award only for BridgeBio, while Soleno Therapeutics and Ionis Pharmaceuticals have non-funded (or contingent) awards recorded at award time. This suggests staged or pending funding for the latter two recipients, with all awards covering multi-year terms through roughly the same program window.
M5-Q50A-03-R8: 65IB Drugs, Pharmaceuticals & Hematology Related Products Solicitation Refreshment
From Presolicitation posted on Dec 10, 2025M5-Q50A-03-R8: 65IB Drugs, Pharmaceuticals & Hematology Related Products Solicitation Refreshment
From Presolicitation posted on Dec 23, 2025M5-Q50A-03-R8: 65IB Drugs, Pharmaceuticals & Hematology Related Products Solicitation Refreshment
From Presolicitation posted on Mar 18, 2026M5-Q50A-03-R8: 65IB Drugs, Pharmaceuticals & Hematology Related Products Solicitation Refreshment
From Presolicitation posted on Apr 02, 2026M5-Q50A-03-R8: 65IB Drugs, Pharmaceuticals & Hematology Related Products Solicitation Refreshment
From Presolicitation posted on Apr 16, 2026M5-Q50A-03-R8: 65IB Drugs, Pharmaceuticals & Hematology Related Products Solicitation Refreshment
From Presolicitation posted on Apr 20, 2026Notice history
10-
Award Notice Posted Jul 11, 2025
-
Award Notice Posted Jul 28, 2025
-
Award Notice Posted Aug 13, 2025
-
Presolicitation Posted Dec 10, 2025View changes (6)
- Title: 6505--Ionis Pharmaceuticals, Inc. Effective 8/15/2025 - 8/14/2030 → M5-Q50A-03-R8: 65IB Drugs, Pharmaceuticals & Hematology Related Products Solicitation Refreshment
- Description: Description was updated
- Notice Type: Award Notice → Presolicitation
- Response Deadline: Not set → Jun 21, 2023
- Set-Aside: None → None
- Status: Inactive → Active
-
Presolicitation Posted Dec 23, 2025No changes from previous notice
-
Award Notice Posted Feb 13, 2026
-
Presolicitation Posted Mar 18, 2026View changes (6)
- Title: 6505--Mesoblast, Inc. Contract Award effective 02/15/2026-02/14/2031 → M5-Q50A-03-R8: 65IB Drugs, Pharmaceuticals & Hematology Related Products Solicitation Refreshment
- Description: Description was updated
- Notice Type: Award Notice → Presolicitation
- Response Deadline: Not set → Jun 21, 2023
- Set-Aside: None → None
- Status: Inactive → Active
-
Presolicitation Posted Apr 02, 2026No changes from previous notice
-
Presolicitation Posted Apr 16, 2026No changes from previous notice
-
Presolicitation LATEST Posted Apr 20, 2026No changes from previous notice
Details
Award Information
Awardees
| Company Name | UEI | CAGE Code | Location |
|---|---|---|---|
| BRIDGEBIO PHARMA, INC. | LSA5MDHDB961 | 8FVJ9 | PALO ALTO |
| SOLENO THERAPEUTICS INC | DA8ADMFJRDU9 | 72XA4 | REDWOOD CITY |
| IONIS PHARMACEUTICALS, INC. | P8PVTLSDNNS6 | 09HU6 | CARLSBAD |
| MESOBLAST, INC. | NNVGHSW7VLM7 | 4QWB3 | NEW YORK |
Contacts
VA Federal Supply Schedule (FSS) Service
Phone